Group 1 - The core viewpoint of the article is the joint initiative by nine government departments in China to enhance the recruitment of research assistant positions for university graduates, aiming to support high-quality employment [1] - The initiative emphasizes the coordination of technology research and development, the growth of quality enterprises, and the development of high-tech industries alongside the creation of research assistant positions [1] - Key tasks outlined include increasing the development of research assistant positions, mobilizing national high-tech zones to create such positions, and encouraging local governments to actively develop research assistant roles [1]

Core Viewpoint - The event aims to establish a high-level communication platform for deep integration between national research institutions and local industries, promoting high-quality development in Ningbo [1][2]. Group 1: Event Overview - The launch event took place on May 27 at the Ningbo Institute of Materials Technology and Engineering, organized by the Ningbo Materials Institute and supported by local government agencies [1]. - Key attendees included Wang Hua, Vice Secretary-General of the Chinese Academy of Sciences, and Xu Yan, Vice Mayor of Ningbo, who emphasized the importance of collaboration between research institutions and local enterprises [1]. Group 2: Key Presentations - Researcher Li Lin from the Ningbo Materials Institute delivered a keynote report titled "The Era Practice of National Strategic Scientific Forces," discussing the role of the Chinese Academy of Sciences in advancing high-level scientific independence and self-reliance [1]. - The report analyzed the unique models of technology transfer and transformation in developed countries and proposed a Ningbo-specific innovation development paradigm for exploring new paths of science-industry integration [1]. Group 3: Participation and Activities - The event attracted 250 representatives from 15 affiliated units of the Chinese Academy of Sciences, local government departments, universities, research institutions, and technology enterprises [2]. - Activities included the release of enterprise needs, presentation of research outcomes, signing of key projects, project negotiations, and expert visits to enterprises, aimed at furthering the deep integration of science and industry [2].

Group 1 - The conference focused on the deep integration of technological innovation and industrial innovation, aiming to explore collaborative development mechanisms among various sectors [3][10] - The establishment of the "Youth Scientist Industry-Academia-Research Innovation Alliance" is intended to enhance the efficiency of technology transfer and address systemic barriers in the commercialization of research outcomes [3][11] - Key discussions included the challenges faced by young scientists in technology transfer, including institutional obstacles and the need for a demand-driven research approach [4][6] Group 2 - Corporate representatives highlighted three core challenges in the layout of cutting-edge technologies: strategic choices in technology paths, high-end talent cultivation, and balancing R&D investment with market returns [7] - Companies called for a collaborative mechanism between academia and industry to manage technological risks and enhance innovation efficiency [7][8] - Suggestions included creating a market-oriented mechanism for technology transfer and establishing transparent policies to support the commercialization of research outcomes [9][10] Group 3 - The conference featured a strategic donation signing ceremony between Xinhua Jin and the China Science and Technology Development Foundation, marking the initiation of practical exploration in the industry-academia-research collaborative innovation mechanism [11] - Projects discussed included advancements in aerospace technology, high-end medical devices, and artificial intelligence, aiming to enhance both fundamental research breakthroughs and industrial transformation efficiency [11][12] - The foundation aims to create an open public platform for collaboration between entrepreneurs and scientists, focusing on solving development challenges rather than merely identifying them [12][13]

导读： 西安出台措施支持科研平台服务产业发展，目标到2027年投用3个以上重大科技基础设施，建成5家陕西实验室及600家以上市 级重点实验室，转化孵化企业100家，攻关关键技术1000项。 特别提示 微信公众号机制调整，请点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 为推动科技创新与产业创新深度融合，更好发挥科研平台对产业发展的服务支撑作用，西安市市政府办公厅印发《西安 市支持重大科技基础设施等科研平台服务产业发展的若干措施》（以下简称《若干措施》）。 《若干措施》所指科研平台包括重大科技基础设施、算力基础设施、国家技术创新中心、国家实验室（基地）、全国重 点实验室、"一带一路"联合实验室、陕西实验室、市级重点实验室等。 根据《若干措施》，西安将加快推进科研平台建设，探索建立多元化投入机制和新型管理机制，进一步增强平台开放共 享水平和服务产业能力，推动相关产业平稳快速发展。到2 0 2 7年，全市投用的重大科技基础设施数量达到3个以上，陕 西实验室达到5家以上，市级及以上重点实验室总数达到6 0 0家以上。依托科研平台转化孵化企业1 0 0家以上，开展关键 核心 ...

东京大学教授佐藤佳的研究室力争接纳美国科学家 "能否让我在日本开展研究？"，东京大学开始陆续接到身在美国的研究人员的咨询。特朗普 政府上台后，美国的研究人员因预算削减而陷入困境。75％的美国研究者"正在考虑离开美 国"。不过，除部分大学外，日本对接纳并不积极。中国和欧洲的态度则不同…… 美国特朗普政府上台后，美国的研究人员因预算削减而陷入困境，北海道大学等日本国内的部分大学已 开始出现试图接纳这些研究人员的动向。如果日本能够从美国迎来优秀人才，将有望提升自身的研究实 力。但与从国家层面积极接纳美国研究人员的欧洲国家等相比，日本的行动较为迟缓。 | 日本 | 东京大学的研究人员正在摸索聘用方案。 北海道大学正在考虑自主的接纳措施 | | --- | --- | | 法国 | 在政府主导下,启动了促进研究机构 接纳外国研究人员的项目 | | Fir Fir | 马克斯 · 普朗克协会将与美国的研究机构 设立联合研究中心 | | | 经济 中文网 | | 中国 | 中国企业在多个SNS上向被解雇的 美国科学家发布广告 | "能否让我在日本开展研究？"，专门研究病毒学的东京大学教授佐藤佳开始陆续接到身在美国的研究人 ...

由湖北省科技信息研究院主办的2025湖北省科技资源共享高质量发展交流培训会在武汉举行。会上发布的《湖北省科技资源开放共享年度报告 （2024）》显示，湖北省科技资源共享服务平台入网实验室达2566个，10万元以上仪器设备20066台套，总原值突破105.79亿元。 湖北是科教大省，创新资源丰富，但创新资源多集中于高校和科研院所，其中就包括大型科学仪器。企业研发需借助先进仪器，但大型科学仪 器价格高昂，对企业来说购买很不划算，甚至无力购买。近年来，我省不断加大科技资源的建设力度，补短板、创特色，探索新模式、新路 径，让"沉睡"的仪器资源高效流转。 "科技资源的共享与高效利用，是破解科技资源配置碎片化、服务效能不均衡等瓶颈问题的关键抓手，也是推动区域创新协同发展的重要路 径。"湖北省科技厅基础研究处处长张智介绍，过去一年，全省科技系统深入贯彻"资源共享、创新协同、质效双升"的工作主线，取得了显著成 效。湖北省科技资源共享服务平台不断优化升级，资源库建设稳步推进，大型仪器设备共享利用率显著提升，科技创新券政策红利持续释放， 区域创新服务能力不断增强。 "大型仪器设备开放共享在推动科研创新、吸引和培养高水平人才方面有 ...

Core Points - Beijing Science and Technology Week will start on May 24, 2025, featuring public access to various scientific innovation platforms [1][2] - The event will include four key institutions: Beijing Institute of Scientific Research, Smart Elderly Care Research Institute, Beijing Planetarium, and Beijing System Nutrition Engineering Technology Center [1][2] Group 1: Scientific Platforms - The "Physical and Chemical Center West Third Ring Laboratory" will open to university students on May 27, showcasing advanced analytical instruments such as scanning electron microscopes and time-of-flight mass spectrometers [1] - The "Smart Health Elderly Care and Service Engineering Key Laboratory" will feature 20 interactive science popularization exhibits focused on elderly care scenarios [1][2] - The "Beijing Planetarium Cosmic Experiment Station" will provide an immersive astronomy exploration experience, transforming abstract concepts into tangible learning [2] Group 2: Public Engagement Activities - The Beijing System Nutrition Engineering Technology Center will offer public tours and educational experiences to dispel dietary myths and promote healthy eating [2] - The event will include the "Science Enlightenment and Museum Tour" featuring activities from various institutions like the National Museum of Nature and Beijing Planetarium [2]

Core Viewpoint - The UK government is accelerating efforts to attract international researchers, particularly those considering leaving the US due to its research policies [1][2]. Group 1: Investment Plans - The UK government, along with the Royal Society and the Royal Academy of Engineering, will announce several investment plans aimed at international researchers [1]. - The Royal Society will establish the "Faraday" scholarship with a total funding of £30 million (approximately $39.89 million), with individual scholarships reaching up to £4 million ($5.32 million) [2]. - The Royal Academy of Engineering has a "Green Future" scholarship program totaling £150 million ($200 million), offering up to £3 million ($3.99 million) for successful applicants over ten years [2]. Group 2: Funding and Support - The UK Department for Science, Innovation and Technology announced a £54 million ($71.81 million) project to attract around ten research teams specializing in life sciences, artificial intelligence, and green energy [2]. - The UK government plans to allocate approximately £2 billion ($2.66 billion) from its annual £20.4 billion ($27.1 billion) R&D budget to support these initiatives [3]. Group 3: Global Context - The US government's cuts to research funding under President Trump have created opportunities for other countries to attract top research talent [3]. - The European Union and France are also making significant investments to attract researchers, with the EU committing €500 million (approximately $560 million) and France pledging €100 million (approximately $110 million) [3]. - A survey indicated that 75% of 1,650 American scientists are considering leaving the US, with Europe and Canada as preferred destinations [3].

Summary of Conference Call Records Industry Overview - The pharmaceutical industry is projected to see a revenue decline of 0.46% in 2024, with net profit attributable to shareholders decreasing by 6.7% and non-recurring net profit declining by approximately 11% [1][4] - In Q1 2025, the fastest-growing sectors include medical services, CXO, and raw materials, while community pharmacies and research services lead in revenue growth [1][4] Key Insights on Specific Sectors Innovative Drug Sector - 23 innovative companies reported a total revenue of 62.8 billion yuan in 2024, reflecting a year-on-year growth of 23.8%, with net profit attributable to shareholders reaching 3.7 billion yuan, significantly outpacing the industry average [1][5] - In Q1 2025, these companies achieved a total revenue of 16.3 billion yuan, marking an 18.7% year-on-year increase, indicating a trend towards profitability [5] Research Services Industry - The research services sector saw a total revenue growth of 6.5% in 2024, although profits declined by 20%-16% [6] - In Q1 2025, total revenue grew by 4.7%, with scale profit increasing by 9% and non-recurring profit rising by 13%, indicating a recovery phase compared to the overall industry decline of 5% [6][7] CXO Industry - The CXO sector experienced a revenue decline in 2024 but rebounded in Q1 2025 with a 13% year-on-year revenue growth and a 23% increase in non-recurring net profit, showcasing strong development potential [8] Chemical Preparations Sector - The chemical preparations industry reported stable revenue in 2024, with a slight increase of 1.2%, and a minimal growth of 0.3% in Q1 2025, indicating a phase of stability [9][10] Raw Materials Sector - The raw materials sector faced a revenue decline of 3.8% in Q1 2025, following a 3.9% decrease in 2024, but non-recurring profit grew by 5%, suggesting that the most challenging phase post-pandemic has passed [10] Medical Devices and Traditional Chinese Medicine - The medical devices industry is projected to grow by 1% in 2024 and 0.3% in Q1 2025, with noticeable profit declines potentially linked to centralized procurement policies [11] - The traditional Chinese medicine sector experienced a 6% revenue decline in Q1 2025 due to high base effects, following a 3.9% decrease in 2024 [11] GLP-1 Receptor Agonists Developments - The development of GLP-1 receptor agonists is trending towards oral formulations and extended half-lives, with multi-target drugs becoming a research focus [3][14] - Notably, the revenue for semaglutide surpassed that of pembrolizumab, indicating strong consumer demand [13] - Companies such as Innovent Biologics, Federated Pharmaceuticals, and Boryung Pharmaceutical are making significant strides in the GLP-1 space [16] Market Performance - The overall pharmaceutical sector saw a 1% increase this week, with a year-to-date rise of 1.2%, slightly underperforming compared to the CSI 300 index, which fell by 1% [2] - Notable individual stock performances included Changshan Pharmaceutical (up 23%), Haichuang Pharmaceutical (up 22%), and Jinkai Biotechnology (up 19%) [2] Conclusion - The pharmaceutical industry is navigating a challenging landscape with mixed performance across sectors, but innovative drugs and specific niches like GLP-1 receptor agonists show promising growth potential. The recovery signs in research services and CXO sectors are noteworthy, indicating potential investment opportunities.

Group 1 - The annual reports of listed companies serve as a comprehensive overview of their operational performance, revealing their development genes, strategic layout, and growth potential [1] - In 2024, 15 companies in the A-share market had a research and development intensity (R&D investment as a percentage of revenue) exceeding 100%, with 10 of these companies not yet profitable [1][2] - Companies maintain high R&D intensity despite not being profitable due to the necessity of R&D for achieving breakthroughs and competitive advantages in the market [2] Group 2 - The relationship between R&D investment and successful outcomes is positive, with sustained high R&D investment being essential for technological breakthroughs [2] - The capital market increasingly values R&D capabilities, as highlighted by the China Securities Regulatory Commission's acknowledgment of a clearer "technology narrative" in the A-share market [2][3] - Investors are shifting focus from short-term profits to long-term growth potential, creating a virtuous cycle of R&D investment leading to innovation, market recognition, and capital infusion [3] Group 3 - The evolving capital market ecosystem offers new financing options through intellectual property (IP) securitization, allowing companies to convert future income from patents and technology into immediate funding [3] - An example of successful IP securitization is the "He Tao Shenzhen-Hong Kong Technology Innovation Cooperation Zone" project, which raised 58 million yuan for eight key research enterprises [3][4] - Emphasizing R&D intensity enables companies to unlock market opportunities, attract capital, and transform intangible assets into tangible financial resources [4]